Midgard Science

Kyinno Bio

Beijing, China kyinno.com From their website, Nov 2026

Work here? Claim this listing

About

Kyinno Bio is a preclinical contract research organization serving biotechnology and pharmaceutical clients. It provides in vitro and in vivo pharmacology, cell line engineering, antibody discovery, and target identification services from Beijing, China, with a business hub in Boston, USA.

Services

  • In vitro services

    Performs cell-based and biochemical in vitro studies for oncology and immunology research, including functional assays and target engagement studies.

  • Cell proliferation assay

    Measures compound effects on cell growth and viability using readouts such as CellTiter-Glo, CellCyte, BrdU, and flow cytometry.

  • MegaScreen cell panel screening

    Screens compounds across a panel of human cancer cell lines for hit identification, lead optimization, and biomarker development.

  • In vivo services

    Offers in vivo pharmacology models for preclinical evaluation, including xenograft, humanized mouse, syngeneic, orthotopic, subcutaneous, and metastasis models.

  • Antibody discovery services

    Provides antibody discovery workflows including common light chain, nanobody discovery, AI-based antibody engineering, and off-target screening.

  • Multispecific antibody development platform

    Develops bispecific, trispecific, and nanobody-based antibodies using proprietary gene-edited mouse platforms.

  • AI-based antibody development platform

    Uses an AI platform to predict antigen-antibody structures and binding affinities, screen antibody sequence libraries, and support affinity maturation.

  • Genetically engineered cell lines

    Develops and supplies engineered cell lines for disease, therapy, and biological process studies.

    Cell line development

1 more services
  • Drug combination services
Turnaround
2 - 14 day Standard Assay Window
What to send
  • Custom assays
  • Custom antibodies
  • Cell lines
  • In vivo model requests

Capabilities

Assays and studies
  • Antibodies
  • In vivo
  • Rodent models
  • Bispecifics
  • ELISA
  • Flow cytometry
10 more
  • Cell proliferation
  • Cell viability
  • Cell panel screening
  • Immuno-oncology assay
  • ADCC
  • ADCP
  • FACS binding assay
  • Internalization assay
  • 3D organoid culture
  • Immune cell assay
Scale and capacity
  • 3000+ engineered cell lines
  • 5000-antibody specificity screening MPSA-AB5000 panel
  • Over 700 sequenced and certified human cancer cell lines
  • 100+ validated assay platforms
  • 6000+ cell lines available
  • 5-floor, 5000m² laboratory
  • 130 professionals
  • Over 1,000 partners
Therapeutic areas
  • Oncology
  • Immunology
  • Cancer drug discovery
  • Cancer drug development

Instruments and platforms

  • CellTiter-Glo
  • CellCyte
  • BrdU
  • Flow cytometry
  • Digital PCR
  • Mass spectrometry

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Cell therapy
Species and models
  • Human cancer cell lines
  • PBMC humanized mouse
  • Syngeneic mouse
  • Orthotopic model
  • Subcutaneous model
  • Metastasis model
3 more
  • Ba/F3 xenograft model
  • Gene-editing xenograft model
  • Luciferase tumor model

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    As listed: GLP-Aligned QC; GLP-Aligned Protocols

Company

Type
CRO
Founded
2017
Team
130 professionals
Quality
GLP-Aligned QC · GLP-Aligned Protocols

Locations

Office
3 Gill Street, suite 100, Woburn, MA, 01801
Sites
Woburn, MA, USA
Serves
Global

Similar labs